Literature DB >> 28649993

κ-Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioral Inhibition.

Antony D Abraham1, Harrison M Fontaine1, Allisa J Song1, Mackenzie M Andrews1, Madison A Baird1, Brigitte L Kieffer2, Benjamin B Land1, Charles Chavkin1.   

Abstract

The dynorphin/κ-opioid receptor (KOR) system has been previously implicated in the regulation of cognition, but the neural circuitry and molecular mechanisms underlying KOR-mediated cognitive disruption are unknown. Here, we used an operational test of cognition involving timing and behavioral inhibition and found that systemic KOR activation impairs performance of male and female C57BL/6 mice in the differential reinforcement of low response rate (DRL) task. Systemic KOR antagonism also blocked stress-induced disruptions of DRL performance. KOR activation increased 'bursts' of incorrect responses in the DRL task and increased marble burying, suggesting that the observed disruptions in DRL performance may be attributed to KOR-induced increases in compulsive behavior. Local inactivation of KOR by injection of the long-acting antagonist nor-BNI in the ventral tegmental area (VTA), but not the infralimbic prefrontal cortex (PFC) or dorsal raphe nucleus (DRN), prevented disruption of DRL performance caused by systemic KOR activation. Cre-dependent genetic excision of KOR from dopaminergic, but not serotonergic neurons, also blocked KOR-mediated disruption of DRL performance. At the molecular level, we found that these disruptive effects did not require arrestin-dependent signaling, because neither global deletion of G-protein receptor kinase 3 (GRK3) nor cell-specific deletion of GRK3/arrestin-dependent p38α MAPK from dopamine neurons blocked KOR-mediated DRL disruptions. We then showed that nalfurafine, a clinically available G-biased KOR agonist, could also produce DRL disruptions. Together, these studies demonstrate that KOR activation in VTA dopamine neurons disrupts behavioral inhibition in a GRK3/arrestin-independent manner and suggests that KOR antagonists could be beneficial for decreasing stress-induced compulsive behaviors.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28649993      PMCID: PMC5729556          DOI: 10.1038/npp.2017.133

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  59 in total

1.  Technique for assessing the effects of drugs on timing behavior.

Authors:  M SIDMAN
Journal:  Science       Date:  1955-11-11       Impact factor: 47.728

2.  The therapeutic potential of κ-opioids for treatment of pain and addiction.

Authors:  Charles Chavkin
Journal:  Neuropsychopharmacology       Date:  2011-01       Impact factor: 7.853

Review 3.  A neural substrate of prediction and reward.

Authors:  W Schultz; P Dayan; P R Montague
Journal:  Science       Date:  1997-03-14       Impact factor: 47.728

4.  Endogenous Opioid Signaling in the Medial Prefrontal Cortex is Required for the Expression of Hunger-Induced Impulsive Action.

Authors:  Ryan A Selleck; Curtis Lake; Viridiana Estrada; Justin Riederer; Matthew Andrzejewski; Ken Sadeghian; Brian A Baldo
Journal:  Neuropsychopharmacology       Date:  2015-04-13       Impact factor: 7.853

5.  Phasic dopamine release in the rat nucleus accumbens symmetrically encodes a reward prediction error term.

Authors:  Andrew S Hart; Robb B Rutledge; Paul W Glimcher; Paul E M Phillips
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

6.  Buprenorphine augmentation in the treatment of refractory obsessive-compulsive disorder.

Authors:  Malcolm B Liddell; Victor Aziz; Patrick Briggs; Nimalee Kanakkehewa; Omar Rawi
Journal:  Ther Adv Psychopharmacol       Date:  2013-02

7.  Kappa-opioid receptor stimulation quickens pathogenesis of compulsive checking in the quinpirole sensitization model of obsessive-compulsive disorder (OCD).

Authors:  Melissa L Perreault; Philip Seeman; Henry Szechtman
Journal:  Behav Neurosci       Date:  2007-10       Impact factor: 1.912

8.  Kappa opioid receptor activation potentiates the cocaine-induced increase in evoked dopamine release recorded in vivo in the mouse nucleus accumbens.

Authors:  Jonathan M Ehrich; Paul E M Phillips; Charles Chavkin
Journal:  Neuropsychopharmacology       Date:  2014-06-27       Impact factor: 7.853

9.  Selective cytotoxic lesions of the hippocampal formation and DRL performance in rats.

Authors:  J D Sinden; J N Rawlins; J A Gray; L E Jarrard
Journal:  Behav Neurosci       Date:  1986-06       Impact factor: 1.912

10.  Sensitivity of the five-choice serial reaction time task to the effects of various psychotropic drugs in Sprague-Dawley rats.

Authors:  Tracie A Paine; Hilarie C Tomasiewicz; Kehong Zhang; William A Carlezon
Journal:  Biol Psychiatry       Date:  2007-03-07       Impact factor: 13.382

View more
  12 in total

1.  Early Adolescence is a Critical Period for the Maturation of Inhibitory Behavior.

Authors:  Lauren M Reynolds; Leora Yetnikoff; Matthew Pokinko; Michael Wodzinski; Julia G Epelbaum; Laura C Lambert; Marie-Pierre Cossette; Andreas Arvanitogiannis; Cecilia Flores
Journal:  Cereb Cortex       Date:  2019-08-14       Impact factor: 5.357

Review 2.  Opioid modulation of cognitive impairment in depression.

Authors:  Moriah L Jacobson; Hildegard A Wulf; Caroline A Browne; Irwin Lucki
Journal:  Prog Brain Res       Date:  2018-09-18       Impact factor: 2.453

3.  Comparative effects of cannabinoid CB1 receptor agonist and antagonist on timing impulsivity induced by d-amphetamine in a differential reinforcement of low-rate response task in male rats.

Authors:  Shuo-Fu Chen; Wei-Chung Hsu; Xi-Yun Lu; Chuen-Yu Chuang; Ruey-Ming Liao
Journal:  Psychopharmacology (Berl)       Date:  2021-11-06       Impact factor: 4.530

4.  A midbrain dynorphin circuit promotes threat generalization.

Authors:  Lizz Fellinger; Yong S Jo; Avery C Hunker; Marta E Soden; Jordan Elum; Barbara Juarez; Larry S Zweifel
Journal:  Curr Biol       Date:  2021-08-12       Impact factor: 10.900

Review 5.  Quantitative Systems Pharmacology and Biased Agonism at Opioid Receptors: A Potential Avenue for Improved Analgesics.

Authors:  Andrea Bedini; Elisabetta Cuna; Monica Baiula; Santi Spampinato
Journal:  Int J Mol Sci       Date:  2022-05-04       Impact factor: 6.208

6.  Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.

Authors:  Antony D Abraham; Selena S Schattauer; Kathryn L Reichard; Joshua H Cohen; Harrison M Fontaine; Allisa J Song; Salina D Johnson; Benjamin B Land; Charles Chavkin
Journal:  J Neurosci       Date:  2018-08-03       Impact factor: 6.167

7.  Downregulation of the neuronal opioid gene expression concomitantly with neuronal decline in dorsolateral prefrontal cortex of human alcoholics.

Authors:  Igor Bazov; Daniil Sarkisyan; Olga Kononenko; Hiroyuki Watanabe; Victor M Karpyak; Tatiana Yakovleva; Georgy Bakalkin
Journal:  Transl Psychiatry       Date:  2018-06-20       Impact factor: 6.222

8.  Highly Potent and Selective New Diphenethylamines Interacting with the κ-Opioid Receptor: Synthesis, Pharmacology, and Structure-Activity Relationships.

Authors:  Filippo Erli; Elena Guerrieri; Tanila Ben Haddou; Aquilino Lantero; Michael Mairegger; Helmut Schmidhammer; Mariana Spetea
Journal:  J Med Chem       Date:  2017-08-30       Impact factor: 7.446

9.  Early life stress dysregulates kappa opioid receptor signaling within the lateral habenula.

Authors:  Sarah C Simmons; Ryan D Shepard; Shawn Gouty; Ludovic D Langlois; William J Flerlage; Brian M Cox; Fereshteh S Nugent
Journal:  Neurobiol Stress       Date:  2020-11-17

10.  Gucy2d selectively marks inhibitory dynorphin neurons in the spinal dorsal horn but is dispensable for pain and itch sensitivity.

Authors:  Elizabeth K Serafin; Robert Burns; Judy Yoo; Mark L Baccei
Journal:  Pain Rep       Date:  2021-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.